Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07009314 · ClinicalTrials.gov registry record · NA
Scaling Out S.A.F.E. Firearm Across Two Health Systems as a Universal Suicide Prevention Strategy (SCALE ASPIRE)
A NA study, sponsored by Northwestern University.
- Not yet
- Registry status
- NA
- Development phase
- 5,442
- Enrollment target
NCT07009314: Clinical Trial NA study, sponsored by Northwestern University.
NCT07009314 is a NA study that has not yet begun recruiting, run by Northwestern University. The registered enrollment target is 5,442 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (288% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07009314, a NA study, has not yet begun recruiting, sponsored by Northwestern University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 5,442 participants
- Enrollment target
Study Summary
In this randomized controlled trial, researchers will assess the expansion of the S.A.F.E. Firearm program into adult primary care and women's health at two health systems in Michigan and Colorado that have previously implemented S.A.F.E. Firearm in pediatrics. S.A.F.E. Firearm involves a brief conversation between health care staff and patients about secure firearm storage and an offer of a free firearm cable lock. Researchers will test S.A.F.E. Firearm and a package of strategies intended to help health care staff incorporate the program into their practice. The strategies include: training, a prompt in the electronic health record, and facilitation, or tailored problem-solving support. The study seeks to answer the following questions: * How effective is S.A.F.E. Firearm at changing patients' firearm storage behavior? * How effective is the implementation strategy package at increasing delivery of the S.A.F.E. Firearm program? Some patients and health care staff will be invited to participate in surveys and/or interviews about their experiences with S.A.F.E. Firearm and the implementation strategy package.
Primary Outcome
Patients who indicate that there are firearms in or around their homes will be asked to report their firearm storage practices in (a) the 2 weeks prior to the visit; and (b) the 2 weeks after the visit. Respondents will indicate whether none, some, or all firearms were stored locked at each time point. Locked storage refers to storage in a container that limits access to the firearm (e.g., safe, cabinet, case) and/or storage with a cable or trigger lock.
Interventions
- BEHAVIORAL Implementation package (training, facilitation, electronic health record nudge)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,442 participants |
| Start Date | 2026-01 |
| Est. Completion | 2028-12 |
| Phase | NA |
What is known before NCT07009314 opens enrollment
NCT07009314 is an interventional study that assigns participants to a tested intervention. Its 5,442 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (288% higher).
The record links to 0 conditions, and to 1 intervention - of which Implementation package (training, facilitation, electronic health record nudge) is the first listed.
NCT07009314 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07009314 about?
NCT07009314 is a clinical study titled "Scaling Out S.A.F.E. Firearm Across Two Health Systems as a Universal Suicide Prevention Strategy (SCALE ASPIRE)". In this randomized controlled trial, researchers will assess the expansion of the S.A.F.E. Firearm program into adult primary care and women's health at two health systems in Michigan and Colorado that have previously implemented S.A.F.E. Firearm in pediatrics. S.A.F.E. Firearm involves a brief conv...
What is the current status of trial NCT07009314?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 5,442 participants. The study started on 2026-01. Estimated completion is 2028-12.
What interventions are being tested in trial NCT07009314?
The interventions under investigation include: Implementation package (training, facilitation, electronic health record nudge) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07009314?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07009314's enrollment target sits among peer trials
5,442 24th of 2000 higher than 1,977 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05722769 · 5,408 participants · NA
CSTOP Now! Child Sex Trafficking Stops With You
- NCT04295486 · 5,478 participants · Phase 2
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
- NCT05952557 · 5,500 participants · Phase 3
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
- NCT06084234 · 5,500 participants · Phase 4
National Liver Cancer Screening Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia